![](/img/cover-not-exists.png)
PCV68 COST-EFFECTIVENESS OF GENOTYPE-DRIVEN ANTIPLATELET THERAPY FOR SECONDARY PREVENTION AFTER ACUTE CORONARY SYNDROME
DJ Crespin, JJ Federspiel, AK Biddle, D Jonas, SC Stearns, JS RossiVolume:
13
Year:
2010
Language:
english
DOI:
10.1016/s1098-3015(10)72787-x
File:
PDF, 77 KB
english, 2010